<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ophthalmic surgery products - Moria - Alchimia</title>
	<atom:link href="https://alchimiasrl.com/information/ophthalmic-surgery/feed/" rel="self" type="application/rss+xml" />
	<link>https://alchimiasrl.com/information/ophthalmic-surgery/</link>
	<description>Your ideas, our solutions</description>
	<lastBuildDate>Thu, 29 Dec 2022 16:58:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://alchimiasrl.com/wp-content/uploads/2020/03/cropped-Icon-per-sito-32x32.jpg</url>
	<title>Ophthalmic surgery products - Moria - Alchimia</title>
	<link>https://alchimiasrl.com/information/ophthalmic-surgery/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Comparison of Perfluorocarbon Liquids Cytotoxicity Tests: Direct Contact Versus the Test on Liquid Extracts</title>
		<link>https://alchimiasrl.com/comparison-of-perfluorocarbon-liquids-cytotoxicity-tests-direct-contact-versus-the-test-on-liquid-extracts/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Thu, 29 Dec 2022 16:58:45 +0000</pubDate>
				<category><![CDATA[HPF]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Perfluorocarbons]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=22744</guid>

					<description><![CDATA[<p>Year: 2022 Authors: Gatto C.; Ruzza P.; Giurgola L.; Honisch C.; Rossi O.; Romano M. R.; Ragazzi E.; D'Amato Tóthová J.     ACS Omega Journal doi/10.1021/acsomega.2c04697 Online version This is a: Publication   The purpose of this study is to compare the in vitro cytotoxicity tests according to the ISO  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/comparison-of-perfluorocarbon-liquids-cytotoxicity-tests-direct-contact-versus-the-test-on-liquid-extracts/">Comparison of Perfluorocarbon Liquids Cytotoxicity Tests: Direct Contact Versus the Test on Liquid Extracts</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-1"><p><strong>Year:</strong> 2022</p>
<p><strong>Authors</strong>: <span class="hlFld-ContribAuthor">Gatto C.; </span><span class="hlFld-ContribAuthor">Ruzza P.; </span><span class="hlFld-ContribAuthor">Giurgola L.; </span><span class="hlFld-ContribAuthor">Honisch C.; </span><span class="hlFld-ContribAuthor">Rossi O.; </span><span class="hlFld-ContribAuthor">Romano M. R.; </span><span class="hlFld-ContribAuthor">Ragazzi E.; D&#8217;Amato Tóthová J.</span></p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-2"><p><span class="journal-name">ACS Omega Journal</span><br />
doi/10.1021/acsomega.2c04697<br />
<a href="https://pubs.acs.org/doi/10.1021/acsomega.2c04697">Online version</a></p>
</div><div class="fusion-text fusion-text-3"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-4"><p id="Abstract" class="article_abstract-title"><span style="font-size: 16px;">The purpose of this study is to compare the in vitro cytotoxicity tests according to the ISO 10993-5 (2009) standards using direct contact and the test on liquid extracts of compounds previously identified as possible toxic impurities in perfluorocarbon liquids (PFCLs) for use in vitreoretinal surgery. Compounds including perfluorooctanoic acid (PFOA), 1</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-perfluorooctane (1H-PFO), 2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-tridecafluoro-2-methylpentane, 1</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">,2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-octafluorocyclopentane, and 2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">,3</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-decafluoropentane were analyzed by </span><sup>19</sup><span style="font-size: 16px;">F NMR before and after extraction using an aqueous solution and tested by both the direct contact and liquid extract tests in L929, BALB 3T3, and ARPE-12 cells. The concentration that reduced in vitro cell viability by 30%, the cytotoxicity concentration threshold (CC</span><sub>30</sub><span style="font-size: 16px;">), was determined for each compound. </span><sup>19</sup><span style="font-size: 16px;">F NMR spectroscopy confirmed the immiscibility of perfluoro-</span><i style="font-size: 16px;">n</i><span style="font-size: 16px;">-octane (PFO) and 1H-PFO and the solubility of PFOA with the extraction vehicle. The other samples reacted with the extraction vehicle, releasing fluoride ions. Using the direct contact test, the CC</span><sub>30</sub><span style="font-size: 16px;"> of PFOA, 1H-PFO, 2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-tridecafluoro-2-methylpentane, 1</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">,2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-octafluorocyclopentane, and 2</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">,3</span><i style="font-size: 16px;">H</i><span style="font-size: 16px;">-decafluoropentane corresponded to 48 124, 50, 14, 8035, and 46 ppm, respectively. The method on liquid extracts did not detect cytotoxicity in three out of five tested compounds, and CC</span><sub>30</sub><span style="font-size: 16px;"> could not be determined. In conclusion, the in vitro cytotoxicity test by direct contact revealed a positive correlation between cell toxicity and the concentration of the tested substance. Conversely, the test on liquid extracts hardly detected the cytotoxicity of toxic impurities in PFCLs. Thus, only the cytotoxicity test by direct contact, according to ISO 10993-5 (2009), is a sensible and reliable method to detect possible cytotoxic impurities in PFCLs to guarantee patient safety.</span></p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/comparison-of-perfluorocarbon-liquids-cytotoxicity-tests-direct-contact-versus-the-test-on-liquid-extracts/">Comparison of Perfluorocarbon Liquids Cytotoxicity Tests: Direct Contact Versus the Test on Liquid Extracts</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ex vivo evaluation of retinal cytotoxicity after the use of multiple medical devices in pars plana vitrectomy in porcine eyes</title>
		<link>https://alchimiasrl.com/ex-vivo-evaluation-of-retinal-cytotoxicity-after-the-use-of-multiple-medical-devices-in-pars-plana-vitrectomy-in-porcine-eyes/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Tue, 23 Nov 2021 16:56:28 +0000</pubDate>
				<category><![CDATA[HPF]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Perfluorocarbons]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[RS-OIL]]></category>
		<category><![CDATA[Silicone oils]]></category>
		<category><![CDATA[Twin]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=21820</guid>

					<description><![CDATA[<p>Year: 2021 Authors: Gatto C.; Romano M.R.; Giurgola L.; Ferrara M.; Ragazzi E.; D'Amato Tóthová J.     Experimental Eye Research  10.1016/j.exer.2021.108837 Online version This is a: Publication   This study aimed to evaluate viability of retinal cells after the use of multiple intraoperative devices, namely a vitreal dye (triamcinolone acetonide,TA), a  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/ex-vivo-evaluation-of-retinal-cytotoxicity-after-the-use-of-multiple-medical-devices-in-pars-plana-vitrectomy-in-porcine-eyes/">Ex vivo evaluation of retinal cytotoxicity after the use of multiple medical devices in pars plana vitrectomy in porcine eyes</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-5"><p><strong>Year:</strong> 2021</p>
<p><strong>Authors</strong>: Gatto C.; Romano M.R.; Giurgola L.; Ferrara M.; Ragazzi E.; D&#8217;Amato Tóthová J.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-6"><p><span class="journal-name">Experimental Eye Research </span><br />
10.1016/j.exer.2021.108837<br />
<a href="https://www.sciencedirect.com/science/article/abs/pii/S0014483521004036?via%3Dihub">Online version</a></p>
</div><div class="fusion-text fusion-text-7"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-8"><div class="align-m">
<p>This study aimed to evaluate viability of retinal cells after the use of multiple intraoperative devices, namely a vitreal dye (triamcinolone acetonide,TA), a ERM/ILM dye (solution of trypan blue 0.15% and brilliant blue 0.025%), and two intraocular tamponades, namely perfluoro-n-octane, (PFO) and silicone oil (SO 1000 cSt), with minimal and maximal removal of their residues, during a simulated pars plana vitrectomy (PPV) in porcine eyes ex-vivo. The in vitro cytotoxicity of each of these compounds was verified on ARPE-19 cells by direct tests according to the ISO 10993-5 (2009). Pars plana vitrectomy was performed on 25 enucleated porcine eyes divided in five groups according to the following conditions: Group A) No surgery control: eye bulbs were kept at room temperature for 40 min; Group B) Sham surgery: PPV with the sole use of BSS for 40 min; Group C) Cytotoxic control: PPV with BSS infusion (20 min) followed by intravitreal injection of 1H-PFO (contact time: 20 min); Group D) Surgery with residues: PPV with BSS infusion and sequential intravitreal injection of TA, ERM/ILM dye, PFO and SO, with minimal removal of each compound after a specified contact-time (overall duration: 40 min); Group E) Surgery with minimal residues: PPV performed as in group D, but with maximal removal of each compound (overall duration: 40 min). All the experimental procedures were performed at room temperature.<br />
Immediately after surgery, the retina was extracted from each eye bulb and samples of 3-mm diameter were prepared. Retinal viability was determined for each sample by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay. A cell viability &lt;70% was considered the cytotoxicity threshold. Kruskal-Wallis test was used to evaluate the differences in retinal viability between groups. No cytotoxicity was detected in retinal samples in groups A, B and E. Samples from eye bulbs that had undergone surgery with minimal removal of residues (group D) and cytotoxic controls (group C) showed high retinal cytotoxicity. The tested conditions indicated that the combined use of TA, ERM/ILM dye, PFO and SO during PPV does not affect retinal cells viability if all the devices are properly removed, whereas the cytotoxicity detected in group D may suggest that the presence and accumulation of the residues of the compounds used intraoperatively could negatively impact retinal viability due to a cumulative and/or synergistic cytotoxic effect between them, supporting the crucial role of an optimal removal of the intraoperative medical devices to ensure a safe vitrectomy to the patient.</p>
</div>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/ex-vivo-evaluation-of-retinal-cytotoxicity-after-the-use-of-multiple-medical-devices-in-pars-plana-vitrectomy-in-porcine-eyes/">Ex vivo evaluation of retinal cytotoxicity after the use of multiple medical devices in pars plana vitrectomy in porcine eyes</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Toxicity Threshold of Perfluorocarbon Liquids for Intraocular Use: Dose–Response Assessment of In Vitro Cytotoxicity of Possible Contaminants</title>
		<link>https://alchimiasrl.com/toxicity-threshold-of-perfluorocarbon-liquids-for-intraocular-use-dose-response-assessment-of-in-vitro-cytotoxicity-of-possible-contaminants/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Wed, 19 May 2021 16:36:09 +0000</pubDate>
				<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Perfluorocarbons]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=21231</guid>

					<description><![CDATA[<p>Year: 2021 Authors: Romano M.; Gatto C.; Giurgola L.; Ragazzi E.; D'Amato Tóthová J.     Translational Vision Science &amp; Technology 10.1167/tvst.10.6.24 Online version This is a: Publication   Purpose: This study assessed the cytotoxicity of the impurities detected in the perfluorooctane (PFO) batches for vitreoretinal surgery that were associated with serious  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/toxicity-threshold-of-perfluorocarbon-liquids-for-intraocular-use-dose-response-assessment-of-in-vitro-cytotoxicity-of-possible-contaminants/">Toxicity Threshold of Perfluorocarbon Liquids for Intraocular Use: Dose–Response Assessment of In Vitro Cytotoxicity of Possible Contaminants</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-9"><p><strong>Year:</strong> 2021</p>
<p><strong>Authors</strong>: Romano M.; Gatto C.; Giurgola L.; Ragazzi E.; D&#8217;Amato Tóthová J.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-10"><p><span class="journal-name">Translational Vision Science &amp; Technology</span><br />
10.1167/tvst.10.6.24<br />
<a href="https://tvst.arvojournals.org/article.aspx?articleid=2772621">Online version</a></p>
</div><div class="fusion-text fusion-text-11"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-12"><div class="align-m">
<p><strong>Purpose</strong>: This study assessed the cytotoxicity of the impurities detected in the perfluorooctane (PFO) batches for vitreoretinal surgery that were associated with serious adverse incidents of ocular toxicity, namely, the perfluorooctanoic acid (PFOA), 1H,1H,7H-dodecafluoro-1-heptanol (DFH), 1H-perfluorooctane (1H-PFO), ethylbenzene, anhydrous p-xylene, and perfluoro-2-butyltetrahydrofurane, and two additional substances 1H,1H,1H,2H,2H-perfluorooctane (5H-PFO) and hexafluoro-1,2,3,4-tetrachlorobutane.</p>
</div>
<div class="collapsable-text readability is-active">
<p><strong>Methods</strong>: Serial dilutions were tested by in vitro direct contact cytotoxicity test, validated in accordance with the ISO 10993-5:2009 standard using BALB3T3 and ARPE-19 cell lines, after sample application for 24 hours.</p>
<p><strong>Results</strong>: Six of the eight tested substances were cytotoxic according to the above-mentioned ISO standard. Anhydrous p-xylene, ethylbenzene, and PFOA were the most cytotoxic impurities as traces 1.55 ppm, 1.06 ppm, and 28.4 ppm reached the cytotoxicity limit, respectively. Hexafluoro-1,2,3,4-tetrachlorobutane, DFH, and 1H-PFO were cytotoxic at 980, 22,500, and 123,000 ppm, respectively. Both 5H-PFO and perfluoro-2-butyltetrahydrofuran were non-cytotoxic at the highest available concentrations (≥970,000 ppm). The dose-response curves allowed to calculate the cytotoxic concentration (CC<sub>30</sub>) for each tested substance that would reduce 30% of cell viability and corresponding to the cytotoxicity threshold according to ISO 10993-5.</p>
<p><strong>Conclusions</strong>: Our study determined the in vitro cytotoxicity of several impurities in PFO associated with serious adverse incidents in retinal surgery patients.</p>
<p><strong>Translational Relevance</strong>: Severe cytotoxicity of some impurities previously found in toxic perfluorocarbon liquids was confirmed. The cytotoxicity test validated according to the ISO 10993-5:2009 standard is a sensible and fast method for reliable detection of the cytotoxicity in perfluorocarbon liquids to guarantee maximal safety for the patients.</p>
</div>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/toxicity-threshold-of-perfluorocarbon-liquids-for-intraocular-use-dose-response-assessment-of-in-vitro-cytotoxicity-of-possible-contaminants/">Toxicity Threshold of Perfluorocarbon Liquids for Intraocular Use: Dose–Response Assessment of In Vitro Cytotoxicity of Possible Contaminants</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>25-gauge vitrectomy with gas tamponade for rhegmatogenous retinal detachment: experienced vs. Inexperienced surgeons</title>
		<link>https://alchimiasrl.com/25-gauge-vitrectomy-with-gas-tamponade-for-rhegmatogenous-retinal-detachment-experienced-vs-inexperienced-surgeons/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Wed, 17 Feb 2021 10:22:51 +0000</pubDate>
				<category><![CDATA[Ophthalmic gases]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=20981</guid>

					<description><![CDATA[<p>Year: 2021 Authors: Pencak M.; Veith M.; Stranak Z.; Dite J.; Vranova J.; Studeny P.     Preprint 10.21203/rs.3.rs-53301/v3 Online version This is a: Preprint   Introduction: To compare the results and complication rates of a 25-gauge pars plana vitrectomy (PPV) with gas tamponade for rhegmatogenous retinal detachment (RRD) between experienced and  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/25-gauge-vitrectomy-with-gas-tamponade-for-rhegmatogenous-retinal-detachment-experienced-vs-inexperienced-surgeons/">25-gauge vitrectomy with gas tamponade for rhegmatogenous retinal detachment: experienced vs. Inexperienced surgeons</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-4 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-13"><p><strong>Year:</strong> 2021</p>
<p><strong>Authors</strong>: Pencak M.; Veith M.; Stranak Z.; Dite J.; Vranova J.; Studeny P.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-14"><p>Preprint<br />
10.21203/rs.3.rs-53301/v3<br />
<a href="https://www.researchsquare.com/article/rs-53301/v3">Online version</a></p>
</div><div class="fusion-text fusion-text-15"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Preprint</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-16"><div class="align-m">
<p><strong>Introduction:</strong> To compare the results and complication rates of a 25-gauge pars plana vitrectomy (PPV) with gas tamponade for rhegmatogenous retinal detachment (RRD) between experienced and inexperienced surgeons.</p>
</div>
<div class="collapsable-text readability is-active">
<p><strong>Materials and Methods:</strong> This is a retrospective comparative consecutive case series study of patients with uncomplicated RRD treated with 25g PPV with gas tamponade. Patients were divided into 2 groups: In experienced surgeon group (ESG) the procedure was performed by an experienced vitreoretinal surgeon and in inexperienced surgeon group (ISG) the procedure was performed by 2 inexperienced surgeons. Anatomical and functional results and complication rates were compared between the two groups.</p>
<p><strong>Results:</strong> 216 eyes were included in the study. In the ESG (106 eyes), the single operation success rate was 94.3%, and the final success rate was 100%. In the ISG (110 eyes), the single operation success rate was 93.6%, and the final success rate was 100.0%. The difference in single surgery success rate between groups was not statistically significant (P = 0.828). The mean postoperative BCVA improvement was 0.348 decimal in ESG and 0.405 decimal in ISG (P = 0.234). The difference in complication rates between groups was not significant.</p>
<p><strong>Conclusions:</strong> A 25g PPV with gas tamponade for treatment of RRD yields excellent anatomical results and improvement in BCVA. With good technique and use of modern vitrectomy machines and instruments, even inexperienced surgeons can achieve high single operation success rate, suggesting a short learning curve. The complication rate is comparable between experienced and inexperienced surgeons.</p>
</div>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/25-gauge-vitrectomy-with-gas-tamponade-for-rhegmatogenous-retinal-detachment-experienced-vs-inexperienced-surgeons/">25-gauge vitrectomy with gas tamponade for rhegmatogenous retinal detachment: experienced vs. Inexperienced surgeons</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid</title>
		<link>https://alchimiasrl.com/intraocular-toxicity-caused-by-meroctane-perfluorocarbon-liquid/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Fri, 15 Jan 2021 15:49:43 +0000</pubDate>
				<category><![CDATA[HPF]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Perfluorocarbons]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=20836</guid>

					<description><![CDATA[<p>Year: 2021 Authors: Coco-Martin R. M.; Andrés-Iglesias C.; Srivastava G. K.; Lagos-Rodriguez J.; Ruiz-Tevah M.; Díaz-Cárdenas M. R.; Fernandez-Bueno I.; García-Serna J.; García-Gutierrez M. T.; García-Layana A.; Pastor J. C.     Sci Rep 11, 599 (2021) doi.org/10.1038/s41598-020-79561-y Online version This is a: Publication   Abstract Serious intraocular toxicity cases have been reported worldwide after  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/intraocular-toxicity-caused-by-meroctane-perfluorocarbon-liquid/">Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-5 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-17"><p><strong>Year:</strong> 2021</p>
<p><strong>Authors</strong>: <a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Rosa_M_-Coco_Martin" aria-pressed="false" aria-expanded="false">Coco-Martin R. M.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Cristina-Andr_s_Iglesias" data-corresp-id="c1" aria-pressed="false" aria-expanded="false">Andrés-Iglesias C.;</a> <a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Girish_K_-Srivastava" aria-pressed="false" aria-expanded="false">Srivastava G. K.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Javier-Lagos_Rodriguez" aria-pressed="false" aria-expanded="false">Lagos-Rodriguez J.;</a> <a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Miguel-Ruiz_Tevah" aria-pressed="false" aria-expanded="false">Ruiz-Tevah M.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Mario_R_-D_az_C_rdenas" aria-pressed="false" aria-expanded="false">Díaz-Cárdenas M. R.;</a> <a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Ivan-Fernandez_Bueno" aria-pressed="false" aria-expanded="false">Fernandez-Bueno I.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Juan-Garc_a_Serna" aria-pressed="false" aria-expanded="false">García-Serna J.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Mar_a_T_-Garc_a_Gutierrez" aria-pressed="false" aria-expanded="false">García-Gutierrez M. T.;</a> <a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-Alfredo-Garc_a_Layana" aria-pressed="false" aria-expanded="false">García-Layana A.; </a><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-author-popup="auth-J__Carlos-Pastor" aria-pressed="false" aria-expanded="false">Pastor</a> J. C.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-18"><p>Sci Rep 11<b>, </b>599 (2021)<br />
doi.org/10.1038/s41598-020-79561-y<br />
<a href="https://www.nature.com/articles/s41598-020-79561-y">Online version</a></p>
</div><div class="fusion-text fusion-text-19"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-9 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-20"><p class="c-article__sub-heading" data-test="abstract-sub-heading"><strong>Abstract</strong><br />
Serious intraocular toxicity cases have been reported worldwide after the use of different perfluorocarbon liquids. The current study reports for the first-time the clinical pictures of cases of acute intraocular toxicity caused by MEROCTANE, a perfluoro-octane commercialized by a Turkish company and distributed in many countries. A series of 18 cases from Chile and Spain was retrospectively analysed. To evaluate the impurity profile, a suspicious MEROCTANE sample (lot OCT.01.2013) was analysed by gas chromatography mass spectrometry and compared with a non-suspicious sample of the same commercial perfluoro-octane (lot OCT 722011). Cytotoxicity was tested following a direct-contact method, taking into consideration the high volatility and hydrophobicity of perfluoro-octane and following the ISO 10993 guideline. Cytotoxicity test showed clear cytotoxic effects of the analysed batch (less than 9% of cell viability). Moreover, chemical analysis demonstrated the presence of many contaminants, some highly toxic (acids and alcohols). Perfluorocarbon liquids are useful tools for intraocular surgery but companies and Agencies of Medical Devices must implement measures that guarantee the safety of these products based on both chemical and cytotoxicity analysis for every batch<b>.</b> Medical staff should be encouraged to report any suspected case to their respective National Agencies.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/intraocular-toxicity-caused-by-meroctane-perfluorocarbon-liquid/">Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Intraoperative efficacy and clinical outcomes of two commercial staining solutions used in idiopathic epiretinal membrane surgery</title>
		<link>https://alchimiasrl.com/intraoperative-efficacy-and-clinical-outcomes-of-two-commercial-staining-solutions-used-in-idiopathic-epiretinal-membrane-surgery/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Mon, 11 Jan 2021 15:48:34 +0000</pubDate>
				<category><![CDATA[Dyes]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[Twin]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=20792</guid>

					<description><![CDATA[<p>Year: 2021 Authors: Iuliano L.; Kacerik E.; Corbelli E.; Bandello F.; Codenotti M.     Int Ophthalmol, 2021 doi.org/10.1007/s10792-020-01660-6 Online version This is a: Publication   Purpose: To compare two commercially available staining solutions (MembraneBlue Dual® by D.O.R.C., Netherlands, and TWIN by AL.CHI.MI.A. S.R.L., Italy), in terms of intraoperative handling, staining  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/intraoperative-efficacy-and-clinical-outcomes-of-two-commercial-staining-solutions-used-in-idiopathic-epiretinal-membrane-surgery/">Intraoperative efficacy and clinical outcomes of two commercial staining solutions used in idiopathic epiretinal membrane surgery</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-6 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-10 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-21"><p><strong>Year:</strong> 2021</p>
<p><strong>Authors</strong>: Iuliano L.; Kacerik E.; Corbelli E.; Bandello F.; Codenotti M.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-22"><p>Int Ophthalmol, 2021<br />
doi.org/10.1007/s10792-020-01660-6<br />
<a href="https://link.springer.com/epdf/10.1007/s10792-020-01660-6?sharing_token=USgQmxNTKldHbyQq-Z6APve4RwlQNchNByi7wbcMAY4aIThR_KXkXqG1pN64CyNKw045QM-G7dGB1qObJMZQymXZSHYB11aTRHTc-dUeIGgVafkHnYnc2CEmw1MTOE2yaFf1ZV-28gDXTSjgQ3OBUiBHQcDGzottr2Ih7NHIeqQ%3D">Online version</a></p>
</div><div class="fusion-text fusion-text-23"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-11 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-24"><p class="c-article__sub-heading" data-test="abstract-sub-heading"><strong>Purpose:</strong> To compare two commercially available staining solutions (MembraneBlue Dual® by D.O.R.C., Netherlands, and TWIN by AL.CHI.MI.A. S.R.L., Italy), in terms of intraoperative handling, staining efficacy and safety, in eyes undergoing surgery for idiopathic epiretinal membrane (ERM).</p>
<p class="c-article__sub-heading" data-test="abstract-sub-heading"><strong>Methods:</strong> In this observational cross-sectional study, the performance of the dyes used during the procedure (cohesion, ERM and internal limiting membrane [ILM] staining efficacy) was scored by the surgeon using a customized questionnaire after 10 procedures with each of the two dyes. Best-corrected visual acuity (BCVA), central foveal thickness (CFT), blue-light fundus autofluorescence (BAF), and microperimetry-determined retinal sensitivity were reviewed preoperatively and then at 1 and 3 months after surgery.</p>
<p class="c-article__sub-heading" data-test="abstract-sub-heading"><strong>Results:</strong> ILM staining efficacy with TWIN was scored 2.89 ± 0.33 by the surgeons, which turned out to be higher than with MembraneBlue Dual® (1.90 ± 0.31, <i>P</i> = 0.0002). The cohesion score was 2.70 ± 0.48 for TWIN and resulted significantly higher than with MembraneBlue Dual® (1.60 ± 0.51, <i>P</i> = 0.0010). BCVA, CFT and retinal sensitivity were similar in the two groups, 1 and 3 months postoperatively (<i>P</i> nonsignificant for all).</p>
<p class="c-article__sub-heading" data-test="abstract-sub-heading"><strong>Conclusions:</strong> Both TWIN and MembraneBlue Dual® dyes showed suitable staining properties and equivalent safety and efficacy profiles, both intra- and postoperatively. The TWIN dye might offer a solution for surgeons who prefer a more cohesive and stable dye.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/intraoperative-efficacy-and-clinical-outcomes-of-two-commercial-staining-solutions-used-in-idiopathic-epiretinal-membrane-surgery/">Intraoperative efficacy and clinical outcomes of two commercial staining solutions used in idiopathic epiretinal membrane surgery</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Safety of silicone oils as intraocular medical device: An in vitro cytotoxicity study</title>
		<link>https://alchimiasrl.com/safety-of-silicone-oils-as-intraocular-medical-device-an-in-vitro-cytotoxicity-study/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Sat, 30 May 2020 09:54:03 +0000</pubDate>
				<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[RS-OIL]]></category>
		<category><![CDATA[Silicone oils]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=19972</guid>

					<description><![CDATA[<p>Year: 2020 Authors: Romano M. R.; Ferrara M.; Gatto C.; Giurgola L.; Zanoni M.; Angi M.; Rinaldi M.; Borgia A.; Sorrentino T.; D'Amato Tóthová J.     Experimental Eye Research: May 2020 doi: 10.1016/j.exer.2020.108018 Online version This is a: Publication   This study aimed to assess the cytotoxic effect of low molecular  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/safety-of-silicone-oils-as-intraocular-medical-device-an-in-vitro-cytotoxicity-study/">Safety of silicone oils as intraocular medical device: An in vitro cytotoxicity study</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-7 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-12 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-25"><p><strong>Year: </strong>2020</p>
<p><strong>Authors</strong>: Romano M. R.; Ferrara M.; Gatto C.; Giurgola L.; Zanoni M.; Angi M.; Rinaldi M.; Borgia A.; Sorrentino T.; D'Amato Tóthová J.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-26"><p>Experimental Eye Research: May 2020<br />
doi: <span class="citation-doi">10.1016/j.exer.2020.108018</span><br />
<a href="https://www.sciencedirect.com/science/article/abs/pii/S0014483520300683?via%3Dihub">Online version</a></p>
</div><div class="fusion-text fusion-text-27"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-13 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-28"><p id="abspara0010">This study aimed to assess the cytotoxic effect of low molecular weight components (LMWC) and conventional silicone oils (SOs) 1000 cSt with different degree of purification (raw, intermediate, and purified) using in vitro cytotoxicity tests. Direct contact cytotoxicity tests were performed in BALB 3T3 and human retinal pigment epithelial cells (ARPE-19) using quantitative and qualitative evaluation according to the ISO 10993-5 (2009) standards. Conventional SOs 1000 cSt in form of raw, intermediate (intermediate product obtained during distillation process), and purified SO (final product after distillation) and a concentrate of LMWC (including siloxane chains with molecular weight up to 1557 g/mol) were directly applied to 100% of cell layer area for 24 h. Cell viability was quantified using 3-(4,5-dimethylthiazole-2-yl)-2,5–28 diphenyltetrazolium bromide (MTT) and neutral red uptake assays in ARPE-19 and BALB3T3, respectively. All tested samples, including the concentrate of LMWC, resulted to be not cytotoxic according to ISO 10993-5 in both qualitative and quantitative evaluations. However, the cellular viability was significantly higher in the intermediate and purified SO compared with the raw SO in ARPE-19 cells. No reduction in cell viability was detected by LMWC.</p>
<p id="abspara0015">The absence of cytotoxicity was observed for all tested samples in both BALB3T3 and ARPE-19 after 24 h of application. A direct cytotoxic effect is not likely to be involved in the potential complications related to SO and LMWC. Long-term potential adverse effects of SO could be related to the raw material and to different concentrations of LMWC.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/safety-of-silicone-oils-as-intraocular-medical-device-an-in-vitro-cytotoxicity-study/">Safety of silicone oils as intraocular medical device: An in vitro cytotoxicity study</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Facing COVID-19 in Ophthalmology Department</title>
		<link>https://alchimiasrl.com/facing-covid-19-in-ophthalmology-department/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Thu, 23 Apr 2020 12:53:33 +0000</pubDate>
				<category><![CDATA[eyeDRO]]></category>
		<category><![CDATA[OCIGEL]]></category>
		<category><![CDATA[Ophthalmic diagnostics]]></category>
		<category><![CDATA[Ophthalmic gels]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=19955</guid>

					<description><![CDATA[<p>Year: 2020 Authors: Romano M R.; Montericcio A.; Montalbano C.; Raimondi R.; Allegrini D.; Ricciardelli G.; Angi M.; Pagano L.; Romano V.     Curr Eye Res: April 23, 2020 - Published online doi: 10.1080/02713683.2020.1752737 Online version This is a: Publication   Purpose: To provide useful guidelines, targeted at ophthalmology professionals, to  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/facing-covid-19-in-ophthalmology-department/">Facing COVID-19 in Ophthalmology Department</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-8 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-14 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-29"><p><strong>Year: </strong>2020</p>
<p><strong>Authors</strong>: Romano M R.; Montericcio A.; Montalbano C.; Raimondi R.; Allegrini D.; Ricciardelli G.; Angi M.; Pagano L.; Romano V.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-30"><p>Curr Eye Res: <span id="ej-journal-date-volume-issue-pg">April 23, 2020 - Published online</span><br />
doi: <span class="citation-doi">10.1080/02713683.2020.1752737</span><br />
<a href="https://www.tandfonline.com/doi/full/10.1080/02713683.2020.1752737">Online version</a></p>
</div><div class="fusion-text fusion-text-31"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-15 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-32"><p><b>Purpose</b>: To provide useful guidelines, targeted at ophthalmology professionals, to minimize COVID-19 infection of both health-care workers and patients.</p>
<p><b>Methods</b>: In this review we present updated literature merged with our experience from hospitals in Bergamo, the epicenter of the COVID-19 European outbreak.</p>
<p><b>Results</b>: Non-pharmaceutical interventions, hygienic recommendations and personal protective equipment to contain viral spread as well as a suggested risk assessment for postponement of non-urgent cases should be applied in ophthalmologist activity. A triage for ophthalmic outpatient clinic is mandatory.</p>
<p><b>Conclusion</b>: Ophthalmology practice should be reorganized in order to face COVID-19.</p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/facing-covid-19-in-ophthalmology-department/">Facing COVID-19 in Ophthalmology Department</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Evaluation of Cytotoxicity of Perfluorocarbons for Intraocular Use by Cytotoxicity Test In Vitro in Cell Lines</title>
		<link>https://alchimiasrl.com/evaluation-of-cytotoxicity-of-perfluorocarbons-for-intraocular-use-by-cytotoxicity-test-in-vitro-in-cell-lines/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Tue, 29 Oct 2019 12:05:02 +0000</pubDate>
				<category><![CDATA[HPF]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Perfluorocarbons]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[R&D Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=18548</guid>

					<description><![CDATA[<p>Year: 2019 Authors: Romano R. M.; Ferrara M.; Gatto C.; Ferrari B.; Giurgola L.; D’Amato Tóthová J.     Translational Vision Science &amp; Technology: October 2019, Vol.8, 24 doi:10.1167/tvst.8.5.24 Online version This is a: Publication   Purpose: To validate the cytotoxicity test of perfluorocarbon liquids (PFCLs) for intraocular use according to the ISO  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/evaluation-of-cytotoxicity-of-perfluorocarbons-for-intraocular-use-by-cytotoxicity-test-in-vitro-in-cell-lines/">Evaluation of Cytotoxicity of Perfluorocarbons for Intraocular Use by Cytotoxicity Test In Vitro in Cell Lines</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-9 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-16 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-image-element fusion-image-align-center in-legacy-container" style="text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);"><div class="imageframe-align-center"><span class=" fusion-imageframe imageframe-none imageframe-3 hover-type-none"><img fetchpriority="high" decoding="async" width="300" height="168" title="TVST logo" src="https://alchimiasrl.com/wp-content/uploads/2019/10/TVST-logo.png" alt class="img-responsive wp-image-18558" srcset="https://alchimiasrl.com/wp-content/uploads/2019/10/TVST-logo-200x112.png 200w, https://alchimiasrl.com/wp-content/uploads/2019/10/TVST-logo.png 300w" sizes="(max-width: 800px) 100vw, 300px" /></span></div></div><div class="fusion-text fusion-text-33"><p><strong>Year: </strong>2019</p>
<p><strong>Authors</strong>: <span class="hlFld-ContribAuthor">Romano R. M.; </span><span class="fontstyle0">Ferrara M.;</span><span class="fontstyle0"> Gatto C.; </span><span class="fontstyle0">Ferrari B.;</span><span class="fontstyle0"> Giurgola L.;</span><span class="fontstyle0"> <span class="hlFld-ContribAuthor">D’Amato Tóthová J.</span></span></p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-34"><p><span class="journal-name">Translational Vision Science &amp; Technology</span>: October 2019, Vol.8, 24<br />
doi:10.1167/tvst.8.5.24<br />
<a href="https://tvst.arvojournals.org/article.aspx?articleid=2753104">Online version</a></p>
</div><div class="fusion-text fusion-text-35"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-17 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-36"><p><strong> <span class="fontstyle0">Purpose: </span></strong><span class="fontstyle2">To validate the cytotoxicity test of perfluorocarbon liquids (PFCLs) for intraocular use according to the ISO 10993-5 standard.<br />
</span></p>
<p><strong><span class="fontstyle0">Methods: </span></strong><span class="fontstyle2">BALB/3T3, ARPE-19 cell lines, and 3-mm human retina <em>ex vivo</em> samples were cultured in 96-well plates. Contact areas of 22%, 59%, and 83% and 2.5-, 12-, and 24-hour contact times were tested in cell lines. Cell viability was quantified by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in ARPE-19 and neutral red uptake (NRU) viability assay for BALB/3T3. Apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay in ARPE-19 cells. 1-H perfluorooctane (1H PFO) and purified perfluorooctane (PFO) were used as cytotoxic and not cytotoxic controls, respectively. Cell viability was assessed by MTT assay in retina<em> ex vivo</em> samples.<br />
</span></p>
<p><span class="fontstyle0"><strong>Results:</strong> </span><span class="fontstyle2">Qualitative evaluation showed that cytotoxic control induced apoptosis, severe reactivity zones, and cytotoxicity according to ISO 10993-5 in all tested conditions. Quantitative evaluation of 1H PFO showed no cytotoxicity according to ISO 10993-5 on 22% areas, whereas cytotoxicity was detected on 59%, and 83% contact areas. The PFO was confirmed not to be cytotoxic in all tested conditions.<br />
</span><span class="fontstyle2">Quantitative evaluation in retina <em>ex vivo</em> samples confirmed no cytotoxicity with PFO and cytotoxicity with 1H PFO.<br />
</span></p>
<p><strong><span class="fontstyle0">Conclusions: </span></strong><span class="fontstyle2">The direct contact cytotoxicity test according to ISO 10993-5 is a suitable method to detect the cytotoxicity of PFCLs and was validated using<br />
quantitative and qualitative approaches in ARPE-19 and BALB/3T3 cells covering 59% of the cell surface areas for 24 hours.<br />
</span></p>
<p><strong><span class="fontstyle0">Translational Relevance: </span></strong><span class="fontstyle2">Direct contact cytotoxicity test using specific conditions was validated, whereas different test conditions could not be validated.</span></p>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/evaluation-of-cytotoxicity-of-perfluorocarbons-for-intraocular-use-by-cytotoxicity-test-in-vitro-in-cell-lines/">Evaluation of Cytotoxicity of Perfluorocarbons for Intraocular Use by Cytotoxicity Test In Vitro in Cell Lines</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Triphasic polymeric corneal coating gel versus a balanced salt solution irrigation during cataract surgery: A postoperative anterior segment optical coherence tomography analysis and confocal microscopy evaluation</title>
		<link>https://alchimiasrl.com/triphasic-polymeric-corneal-coating-gel-versus-a-balanced-salt-solution-irrigation-during-cataract-surgery-a-postoperative-anterior-segment-optical-coherence-tomography-analysis-and-confocal-microsco/</link>
		
		<dc:creator><![CDATA[Michela Stocco]]></dc:creator>
		<pubDate>Wed, 04 Sep 2019 16:47:58 +0000</pubDate>
				<category><![CDATA[eyeDRO]]></category>
		<category><![CDATA[Ophthalmic gels]]></category>
		<category><![CDATA[Ophthalmic surgery products]]></category>
		<category><![CDATA[Publications]]></category>
		<category><![CDATA[home]]></category>
		<guid isPermaLink="false">https://alchimiasrl.com/?p=20897</guid>

					<description><![CDATA[<p>Year: 2019 Authors: Mencucci R.; Cennamo M.; Favuzza E.; Rechichi M.; Rizzo S.     Journal of Cataract &amp; Refractive Surgery, doi: 10.1016/j.jcrs.2019.03.002 Online version  This is a: Publication   Purpose: To investigate the safety and efficacy of the intraoperative use of a triphasic polymeric gel as corneal coating during  [...]</p>
<p>L'articolo <a href="https://alchimiasrl.com/triphasic-polymeric-corneal-coating-gel-versus-a-balanced-salt-solution-irrigation-during-cataract-surgery-a-postoperative-anterior-segment-optical-coherence-tomography-analysis-and-confocal-microsco/">Triphasic polymeric corneal coating gel versus a balanced salt solution irrigation during cataract surgery: A postoperative anterior segment optical coherence tomography analysis and confocal microscopy evaluation</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-10 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-18 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first" style="--awb-bg-size:cover;width:33.333333333333%;width:calc(33.333333333333% - ( ( 4% ) * 0.33333333333333 ) );margin-right: 4%;"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-37"><p><strong>Year:</strong> 2019</p>
<p><strong>Authors:</strong> Mencucci R.; Cennamo M.; Favuzza E.; Rechichi M.; Rizzo S.</p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:0px;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;"></div></div><div class="fusion-sep-clear"></div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:15px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-38"><p>Journal of Cataract &amp; Refractive Surgery, doi: 10.1016/j.jcrs.2019.03.002<br />
<a href="https://journals.lww.com/jcrs/Abstract/2019/08000/Triphasic_polymeric_corneal_coating_gel_versus_a.15.aspx">Online version</a></p>
</div><div class="fusion-sep-clear"></div><div class="fusion-separator fusion-full-width-sep" style="margin-left: auto;margin-right: auto;margin-top:5px;width:100%;"></div><div class="fusion-sep-clear"></div><div class="fusion-text fusion-text-39"><p><span style="float: left; padding-top: 8px;">This is a: </span><span style="font-size: 14px; width: 150px; padding: 8px; display: inline-block; margin-bottom: 40px; color: white; background-color: #002f59; padding-left: 15px; margin-left: 10px;">Publication</span></p>
</div><div class="fusion-clearfix"></div></div></div><div class="fusion-layout-column fusion_builder_column fusion-builder-column-19 fusion_builder_column_2_3 2_3 fusion-two-third fusion-column-last" style="--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% ) * 0.66666666666667 ) );"><div class="fusion-column-wrapper fusion-flex-column-wrapper-legacy"><div class="fusion-text fusion-text-40"><p class="title"><strong class="sub-title" style="font-size: 16px;">Purpose: </strong><span style="font-size: 16px;">To investigate the safety and efficacy of the intraoperative use of a triphasic polymeric gel as corneal coating during cataract surgery and its effect on postoperative ocular comfort.</span></p>
<div id="enc-abstract" class="abstract-content selected">
<p><strong class="sub-title">Setting: </strong>Eye Clinic, University of Florence, Italy.</p>
<p><strong class="sub-title">Design: </strong>Longitudinal observational retrospective study.</p>
<p><strong class="sub-title">Methods: </strong>Data on patients who received an application of a polysaccharide blend of hydroxypropyl methylcellulose, xanthan gum, and carrageenan (EyeDRO) on the corneal surface and data on patients who received a balanced salt solution during phacoemulsification surgery were analyzed. The central corneal thickness (CCT) and epithelial thickness were examined using anterior segment optical coherence tomography, and the corneal basal epithelial cell (BEC) and Langerhans cell densities by in vivo confocal microscopy. The ocular surface disease index (OSDI) score, tear breakup time (TBUT), and Schirmer test I values were evaluated.</p>
<p><strong class="sub-title">Results: </strong>The study comprised data on 28 patients in the coating gel group and 26 patients in the balanced salt solution group. In the coating gel group, the CCT and epithelial thickness values returned to the baseline value within 5 and 15 postoperative days, respectively; the BEC and Langerhans cell densities returned to baseline levels within 15 and 30 postoperative days. In the balanced salt solution group, the mean BEC and Langerhans cell densities were significantly different from the preoperative values at all follow-up assessments. The TBUT returned to the preoperative level at day 5 in the coating gel group. The OSDI scores returned to the preoperative values after 15 days in the coating gel group and 30 days in the balanced salt solution group.</p>
<p><strong class="sub-title">Conclusions: </strong>The use of a tripolymeric gel as a corneal coating during cataract surgery played a protective role on the corneal surface and reduced postoperative discomfort symptoms.</p>
</div>
</div><div class="fusion-clearfix"></div></div></div></div></div>
<p>L'articolo <a href="https://alchimiasrl.com/triphasic-polymeric-corneal-coating-gel-versus-a-balanced-salt-solution-irrigation-during-cataract-surgery-a-postoperative-anterior-segment-optical-coherence-tomography-analysis-and-confocal-microsco/">Triphasic polymeric corneal coating gel versus a balanced salt solution irrigation during cataract surgery: A postoperative anterior segment optical coherence tomography analysis and confocal microscopy evaluation</a> proviene da <a href="https://alchimiasrl.com">Moria - Alchimia</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
